Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
PLoS Med
March 2023
Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Background: Current or recent use of combined oral contraceptives (containing oestrogen+progestagen) has been associated with a small increase in breast cancer risk. Progestagen-only contraceptive use is increasing, but information on associated risks is limited. We aimed to assess breast cancer risk associated with current or recent use of different types of hormonal contraceptives in premenopausal women, with particular emphasis on progestagen-only preparations.
View Article and Find Full Text PDFKnowledge and attitude of Palestinian women to contraceptives: a cross-sectional study.
Lancet
July 2021
Faculty of Pharmacy, Al-Quds University, Jerusalem, occupied Palestinian territory. Electronic address:
Background: Contraceptives have documented efficiency, but outcomes are highly dependent on women's understanding of how they should be used. We assessed the knowledge and attitudes of married Palestinian women about contraceptives and understanding of use of the available methods and side-effects.
Methods: This cross-sectional study involved married Palestinian women of childbearing age (18-50 years), and was done between Jan 20, 2017, and Jan, 1, 2018.
Hormonal contraceptive use and subjective sleep reports in women: An online survey.
J Sleep Res
December 2020
Departamento de Psicobiologia, Universidade Federal de São Paulo, São Paulo, Brazil.
Female sexual hormones have known hypnogenic effects and the use of hormonal replacement therapy in postmenopausal women leads to improvement in sleep quality. However, the effects of hormonal contraceptives in women of reproductive age are still scarcely understood. This study sought to evaluate the impact of hormonal contraceptive use on subjective self-reports of sleep through a web-based cross-sectional survey.
View Article and Find Full Text PDFPositive effects of the progestin desogestrel 75 μg on migraine frequency and use of acute medication are sustained over a treatment period of 180 days.
J Headache Pain
December 2015
Department of Reproductive Endocrinology, University Hospital Zürich, Rämistrasse 100, CH - 8091, Zürich, Switzerland,
Background: Premenopausal migraines frequently are associated with fluctuations of estrogen levels. Both, migraine and combined hormonal contraceptives (CHC) increase the risk of vascular events. Therefore progestagen-only contraceptives (POC) are a safer alternative.
View Article and Find Full Text PDFHormonal contraceptive use and risk of glioma among younger women: a nationwide case-control study.
Br J Clin Pharmacol
April 2015
Department of Neurology, Odense University Hospital, Sdr. Boulevard 29, 5000, Odense, Denmark; Institute of Clinical Research, Faculty of Health Sciences, University of Southern Denmark, Sdr. Boulevard 29, 5000, Odense, Denmark.
Aim: Oral contraceptive use influences the risk for certain cancers. However, few studies have examined any link with risk of central nervous system tumours. We investigated the association between hormonal contraceptive use and glioma risk among premenopausal women in a population-based setting.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!